← United States · Coverage record
US · SEC FORM 4
MeiraGTx Holdings plc
MGTX · Nasdaq · CIK 0001735438 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
8 Form 4 transaction lines observed in the same window
6 sales · 2 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-08-12 · EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 5,996,760
- Previous report
- 4,011,818
- Avg daily volume
- 1,190,432
- Days to cover
- 5.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-08-12 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Purchase (P) | Ordinary Shares | 1,250,000 | USD 4.00 | USD 5,000,000 | SEC filing ↗ |
| 2023-05-05 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Purchase (P) | Ordinary Shares | 4,347,826 | USD 5.75 | USD 25,000,000 | SEC filing ↗ |
| 2022-06-03 | Zeldin Robert K | Purchase (P) | Ordinary Shares | 5,000 | USD 7.90 | USD 39,500 | SEC filing ↗ |
| 2022-05-25 | Wollin Robert J | Purchase (P) | Ordinary Shares | 1,000 | USD 7.94 | USD 7,940 | SEC filing ↗ |
| 2020-11-23 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Purchase (P) | Ordinary Shares | 500,000 | USD 12.85 | USD 6,425,000 | SEC filing ↗ |
Form 4 evidence
46 transaction lines in the latest 365-day window; 236 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Naylor Stuart | Sale (S) | Ordinary Shares | 27,659 | USD 10.64 | USD 294,292 | SEC filing ↗ |
| 2026-08-18 | Forbes Alexandria | Sale (S) | Ordinary Shares | 62,000 | USD 13.86 | USD 859,320 | SEC filing ↗ |
| 2026-07-21 | Giroux Richard | Sale (S) | Ordinary Shares | 56,000 | USD 12.51 | USD 700,560 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Naylor Stuart | Sale (S) | Ordinary Shares | 27,659 | USD 10.64 | USD 294,292 | SEC filing ↗ |
| 2026-08-18 | Forbes Alexandria | Sale (S) | Ordinary Shares | 62,000 | USD 13.86 | USD 859,320 | SEC filing ↗ |
| 2026-07-21 | Giroux Richard | Sale (S) | Ordinary Shares | 56,000 | USD 12.51 | USD 700,560 | SEC filing ↗ |
| 2026-07-07 | Naylor Stuart | Sale (S) | Ordinary Shares | 27,659 | USD 14.80 | USD 409,470 | SEC filing ↗ |
| 2026-06-10 | Harris Keith R. | Option exercise / conversion (M) | Ordinary Shares | 75,000 | USD — | USD — | SEC filing ↗ |
| 2026-05-27 | Giroux Richard | Gift (G) | Ordinary Shares | 7,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-19 | Forbes Alexandria | Sale (S) | Ordinary Shares | 62,000 | USD 9.17 | USD 568,540 | SEC filing ↗ |
| 2026-04-21 | Giroux Richard | Sale (S) | Ordinary Shares | 56,000 | USD 10.22 | USD 572,320 | SEC filing ↗ |
| 2026-04-17 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Award / grant (A) | Ordinary Shares | 555,555 | USD 9.00 | USD 4,999,995 | SEC filing ↗ |
| 2026-04-07 | Naylor Stuart | Sale (S) | Ordinary Shares | 27,661 | USD 9.36 | USD 258,907 | SEC filing ↗ |
| 2026-03-24 | Forbes Alexandria | Sale (S) | Ordinary Shares | 62,000 | USD 7.41 | USD 459,420 | SEC filing ↗ |
| 2026-02-21 | Zeldin Robert K | Option exercise / conversion (M) | Ordinary Shares | 7,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-21 | Zeldin Robert K | Tax withholding (F) | Ordinary Shares | 2,952 | USD 7.45 | USD 21,992 | SEC filing ↗ |
| 2026-02-21 | Wollin Robert J | Option exercise / conversion (M) | Ordinary Shares | 11,250 | USD — | USD — | SEC filing ↗ |
| 2026-02-21 | Wollin Robert J | Tax withholding (F) | Ordinary Shares | 5,949 | USD 7.45 | USD 44,320 | SEC filing ↗ |
| 2026-02-21 | Naylor Stuart | Option exercise / conversion (M) | Ordinary Shares | 25,000 | USD — | USD — | SEC filing ↗ |
| 2026-02-21 | Naylor Stuart | Tax withholding (F) | Ordinary Shares | 11,750 | USD 7.45 | USD 87,538 | SEC filing ↗ |
| 2026-02-21 | Giroux Richard | Option exercise / conversion (M) | Ordinary Shares | 60,000 | USD — | USD — | SEC filing ↗ |
| 2026-02-21 | Giroux Richard | Tax withholding (F) | Ordinary Shares | 31,726 | USD 7.45 | USD 236,359 | SEC filing ↗ |
| 2026-02-21 | Forbes Alexandria | Option exercise / conversion (M) | Ordinary Shares | 62,500 | USD — | USD — | SEC filing ↗ |
| 2026-02-21 | Forbes Alexandria | Tax withholding (F) | Ordinary Shares | 33,048 | USD 7.45 | USD 246,208 | SEC filing ↗ |
| 2026-01-17 | Zeldin Robert K | Option exercise / conversion (M) | Ordinary Shares | 35,000 | USD — | USD — | SEC filing ↗ |
| 2026-01-17 | Zeldin Robert K | Tax withholding (F) | Ordinary Shares | 13,951 | USD 7.42 | USD 103,516 | SEC filing ↗ |
| 2026-01-17 | Wollin Robert J | Option exercise / conversion (M) | Ordinary Shares | 50,000 | USD — | USD — | SEC filing ↗ |
| 2026-01-17 | Wollin Robert J | Tax withholding (F) | Ordinary Shares | 27,206 | USD 7.42 | USD 201,869 | SEC filing ↗ |
| 2026-01-17 | Naylor Stuart | Option exercise / conversion (M) | Ordinary Shares | 75,000 | USD — | USD — | SEC filing ↗ |
| 2026-01-17 | Naylor Stuart | Tax withholding (F) | Ordinary Shares | 35,250 | USD 7.42 | USD 261,555 | SEC filing ↗ |
| 2026-01-17 | Giroux Richard | Option exercise / conversion (M) | Ordinary Shares | 310,000 | USD — | USD — | SEC filing ↗ |
| 2026-01-17 | Giroux Richard | Tax withholding (F) | Ordinary Shares | 163,916 | USD 7.42 | USD 1,216,257 | SEC filing ↗ |
| 2026-01-17 | Forbes Alexandria | Option exercise / conversion (M) | Ordinary Shares | 310,000 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | MGTX |
| CIK | 0001735438 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 236 transaction lines from 2020-01-21 to 2026-10-06 6 P purchase lines · 86 S sale lines · 144 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.